Bulevirtide, Brelovitug
Chronic Hepatitis D
Phase II/III
Recruiting
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Mar 02, 2026
―
Livmarli Oral Product, Maralixibat
Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis
Phase IV
Recruiting
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
Sep 17, 2025
Maralixibat
Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis, Cholestatic Liver Disease
Phase II
Completed
A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
Jan 25, 2021
―
Volixibat
Primary Sclerosing Cholangitis
Phase II
Active Not Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
Nov 17, 2020
―
Maralixibat
Biliary Atresia
Phase II
Completed
Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
Aug 20, 2020
―
Maralixibat
Progressive Familial Intrahepatic Cholestasis (Pfic)
Phase III
Completed
An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
Dec 02, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mirum Pharmaceuticals Inc (MIRM) have in its pipeline
MIRM is currently developing the following drugs: [14C]-Mrm-3379, Bulevirtide, Brelovitug, Low Dose Of Mrm-3379, Middle Dose Of Mrm-3379, High Dose Of Mrm-3379, Low Dose Of Mrm-3379 Open-Label. These drug candidates are in various stages of clinical development as the company works toward FDA approval.